Jerry Ingrande

Publication Details

  • Anesthetic Pharmacology and the Morbidly Obese Patient. Current anesthesiology reports Ingrande, J., Lemmens, H. J. 2013; 3 (1): 10-17


    Anesthesiologists are increasingly being faced with treating obese patients. Physiologic and anthropometric associated with obesity-most notably increases in cardiac output, changes in tissue perfusion and increases in total body weight (TBW), lean body weight (LBW), and fat mass affect the pharmacokinetics (PK) of anesthetic agents. In addition, redundancy of airway tissue, obstructive and central sleep apnea and CO2 retention affect the pharmacodynamics (PD) of anesthetics and narrow the therapeutic window of numerous anesthetic drugs. Safe and effective pharmacologic management of the obese patient requires a thorough understanding of how obesity affects the PK and PD of anesthetics.

    View details for PubMedID 23525377

Stanford Medicine Resources:

Footer Links: